T1	Participants 78 111	advanced nasopharyngeal carcinoma
T2	Participants 368 394	patients with advanced NPC
T3	Participants 451 533	284 patients with 1992 American Joint Committee on Cancer stage III to IV (M0) NPC
T4	Participants 1790 1816	patients with advanced NPC
